Engineered downregulation of Itpr1 expression protected AD model mice from Aβ accumulation, tau hyperphosphorylation, as well as from dysfunction of memory and hippocampal LTP (Shilling et al., 2014). Here, MAPT is linked to Alzheimer disease.